Anti-Infective Drugs Advisory Committee

 June 02, 2009

BRIEFING INFORMATION

 

  FDA

Disclaimer  

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material (pdf)

Appendix 1 (pdf)

Appendix 2 (pdf)

 

Advanced Life Sciences

  Disclaimer  

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Material (pdf)